Omnicell (OMCL) Tops Q2 EPS by 8c, Offers Q3 Guidance

Omnicell (NASDAQ: OMCL) reported Q2 EPS of $0.31, $0.08 better than the analyst estimate of $0.23. Revenue for the quarter came in at $181.2 million versus the consensus estimate of $174.33 million.

GUIDANCE:

Omnicell sees Q3 2017 EPS of $0.38-$0.45, versus the consensus of $0.46. Omnicell sees Q3 2017 revenue of $188-194 million, versus the consensus of $200.2 million.

For earnings history and earnings-related data on Omnicell (OMCL) click here.

You May Also Be Interested In

• Is the global equity rally broadening? UBS weighs in
• JPMorgan Reiterates Overweight Rating on Dixon Technologies India Ltd (DIXON:IN)
• Kura Oncology (KURA) Reiterated at Market Outperform by Citizens Post Q2 Results